선택적 제품 분석
허용하는 경우 개인정보 보호를 고려한 제한적 분석을 사용해 어떤 리서치 여정이 효과적인지 파악합니다. 광고 추적기나 세션 녹화는 사용하지 않습니다. 환경설정에서 이 선택을 변경할 수 있습니다. 자세한 내용은 개인정보 처리방침.
Altria Group, Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $125.4B | |
|---|---|---|
| Revenue (ttm) | 20.4B | |
| Net income (ttm) | 8B | |
| EPS (ttm) | $4.75 | |
| Shares out | 1.7B | |
| P/E (trailing) | 15.3x | |
| P/E (forward) | 11.9x | |
| Dividend | $4.44 (6.09%) | |
| Volume | 4,522,438 | |
| Beta | 0.46 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $26.01B | $25.10B | $24.48B | $24.02B | $23.28B | -2.7% |
| Gross profit | $13.99B | $14.25B | $14.28B | $14.37B | $14.54B | +1.0% |
| Operating income | $11.56B | $11.92B | $11.55B | $11.24B | $9.90B | -3.8% |
| Net income | $2.48B | $5.76B | $8.13B | $11.26B | $6.95B | +29.4% |
| EPS (diluted) | $1.34 | $3.19 | $4.57 | $6.54 | $4.12 | +32.4% |
| EBITDA | $5.26B | $8.74B | $12.32B | $15.07B | $10.83B | +19.8% |
| R&D | $145.0M | $162.0M | $220.0M | $208.0M | $195.0M | +7.7% |
| SG&A | $2.43B | $2.33B | $2.77B | $214.0M | $2.26B | -1.8% |
Recent company headlines from major financial publishers.
The Base scenario reflects the modal operating path: combustible volume secular decline is successfully mitigated by disciplined, continuous price realization. Marlboro maintains premium dominance while discount brands like Basic capture trade-down smokers. Smoke-free progress is modest, with on! growing absolute volume but losing pouch category share to dominant competitors, and NJOY remaining sidelined. Operating cash flow remains robust around $9.0B-$9.5B, enabling steady dividend payments ($4.44 per share) and modest share buybacks. However, with market price ($75.11) exceeding mid fair value ($61.61), investor returns are constrained.
In the Bull scenario, adult consumer discretionary income recovers, curtailing discount trade-down. Regulatory enforcement against illicit disposable vapes redirects nicotine volume back into Marlboro and authorized oral nicotine pouches. Helix's national rollout of on! PLUS across 120,000 stores scales rapidly, turning the smoke-free segment into an accretive profit driver. Altria's FCF generation comfortably supports annual dividend increases and >$1B in annual share repurchases, justifying valuation near the top of the fair value range ($84.57).
| Ke ↓ / g → | 1.0% | 1.3% | 1.5% | 1.8% | 2.0% |
|---|---|---|---|---|---|
| 6.5% | $66.7 | $68.5 | $70.4 | $72.7 | $75.2 |
| 7.0% | $62.6 | $64.0 | $65.6 | $67.3 | $69.3 |
| 7.5% | $59.2 | $60.4 | $61.6 | $63.0 | $64.5 |
| 8.0% | $56.2 | $57.2 | $58.3 | $59.4 | $60.6 |
| 8.5% | $53.7 | $54.5 | $55.4 | $56.3 | $57.3 |
Upcoming earnings date and setup when available.
매월 발행된 리서치 판이 부여한 등급입니다. 등급은 분석 시점의 가격을 공정 가치와 비교한 것이며, 판단이 맞았는지에 대한 기록이 아닙니다.
| 연도 | 1월 | 2월 | 3월 | 4월 | 5월 | 6월 | 7월 | 8월 | 9월 | 10월 | 11월 | 12월 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |